BETTONI, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 1.289
EU - Europa 1.167
AS - Asia 690
SA - Sud America 3
AF - Africa 1
Totale 3.150
Nazione #
US - Stati Uniti d'America 1.269
CN - Cina 260
TR - Turchia 253
UA - Ucraina 221
IE - Irlanda 183
SE - Svezia 166
GB - Regno Unito 130
FR - Francia 126
IT - Italia 126
IN - India 117
DE - Germania 72
SG - Singapore 57
FI - Finlandia 46
PL - Polonia 38
RU - Federazione Russa 25
CA - Canada 19
AT - Austria 14
BE - Belgio 11
CZ - Repubblica Ceca 6
BR - Brasile 3
ES - Italia 2
IL - Israele 2
CH - Svizzera 1
EG - Egitto 1
JP - Giappone 1
MX - Messico 1
Totale 3.150
Città #
Chandler 272
Jacksonville 226
Dublin 183
Izmir 147
Southend 104
Dearborn 83
Princeton 78
Ashburn 70
Nanjing 67
Ann Arbor 53
Beijing 52
Cambridge 52
Wilmington 49
Singapore 40
Kraków 38
Kocaeli 33
Woodbridge 25
Nanchang 22
Tianjin 18
Washington 18
Houston 17
Hebei 16
Boardman 15
Chieti 15
Jiaxing 14
Ottawa 14
Vienna 14
Altamura 13
Kunming 12
Los Angeles 12
Shenyang 12
Brussels 11
Augusta 10
Orange 10
Santa Clara 10
Ningbo 9
San Mateo 9
Changsha 8
Helsinki 8
Auburn Hills 7
Leawood 7
Bosa 6
Fano 5
Hangzhou 5
Jinan 5
Norwalk 5
Toronto 5
Zhengzhou 5
Falls Church 4
Ferrara 4
Grevenbroich 4
Guangzhou 4
Moscow 4
New York 4
San Vito Chietino 4
Brno 3
Olomouc 3
Salerno 3
Bangalore 2
Cagliari 2
Changchun 2
Evanston 2
Lanzhou 2
Messina 2
Milan 2
Munich 2
Nürnberg 2
Pontassieve 2
Rome 2
Teramo 2
Ahmedabad 1
Apo 1
Aquila 1
Arezzo 1
Bologna 1
Brasília 1
Cairo 1
Caramanico Terme 1
Castel 1
Cedar Knolls 1
Chengdu 1
Chicago 1
Como 1
Düsseldorf 1
Fuzhou 1
Haikou 1
Hanover 1
Hefei 1
Kumar 1
L'aquila 1
La Laguna 1
London 1
Milanese 1
Missaglia 1
Modugno 1
Monteroni D'arbia 1
Mountain View 1
New Delhi 1
Odesa 1
Palermo 1
Totale 2.000
Nome #
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 124
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 120
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 114
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 112
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 112
Synthesis of diastereomerically enriched 2-bromoesters and their reaction with nucleophiles 111
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 101
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 100
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 97
Synthesis and antiplatelet activity of gemfibrozil chiral analogues 95
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 91
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 90
Chiral analogues of clofibrate: dynamic kinetic resolution via 2-bromoimides 89
Direct resolution of α-monoalkyl-α-aryloxyacetic acids via ester or imide derivatives 89
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 89
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 86
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 85
Enantiomeric separation of some demethylated analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 85
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 84
Asymmetric synthesis of enantiomerically enriched chiral fibrates, thiols and aminoacids 81
Synthesis of 2-aryloxy acids analogues of clofibrate via dynamic kinetic resolution 80
Enantioseparazione di analoghi chirali dei fibrati in Elettroforesi Capillare e nano-Cromatografia Liquida 79
Isosteres of chiral clofibric acid analogs: synthesis, resolution, absolute configuration and HPLC detection of the optical purity 78
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 77
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 75
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 74
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 74
Antiplatelet activity of gemfibrozil chiral analogues 72
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 70
Asma e broncopneumopatia cronica ostruttiva 67
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 67
Antitrombotici, trombolitici,coagulanti e sostitutiemoplasmatici 66
N-substituted acetamidines as nitric oxide synthase inhibitors 63
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 63
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 62
Synthesis of (R) Aryloxy acids by SN2 Reaction from Diastereomerically Enriched alpha-Bromo Esters 61
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 60
Prospettiva storica della chimica farmaceutica 57
Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication 36
Totale 3.236
Categoria #
all - tutte 9.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020428 0 36 3 26 35 52 100 46 19 56 52 3
2020/2021335 42 2 42 3 21 49 4 6 68 73 0 25
2021/2022178 4 1 6 21 30 5 6 13 18 7 20 47
2022/2023676 43 106 45 82 66 134 33 46 78 5 21 17
2023/2024314 15 9 38 12 21 91 67 6 2 15 4 34
2024/202585 26 59 0 0 0 0 0 0 0 0 0 0
Totale 3.236